Summit Therapeutics
Nindhana Paranthaman, MD, MBA, is an accomplished Executive Medical Director currently leading clinical development at Summit Therapeutics, Inc., focusing on the innovative anti-PD-1/VEGF bispecific antibody ivonescimab. With extensive experience in oncology, Nindhana has previously held senior roles at Exelixis, Genentech, Amgen, and Bristol Myers Squibb, driving clinical strategies for multiple oncology assets and overseeing complex trials. A graduate of The Johns Hopkins University with an MBA and Sri Ramachandra Institute of Higher Education and Research with an MD, Nindhana combines clinical expertise with strategic leadership to advance therapeutic innovations in cancer treatment.
This person is not in any teams
This person is not in any offices